Pan Xu

635 total citations
16 papers, 488 citations indexed

About

Pan Xu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Pan Xu has authored 16 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Pan Xu's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Cancer-related molecular mechanisms research (7 papers) and Autophagy in Disease and Therapy (3 papers). Pan Xu is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Cancer-related molecular mechanisms research (7 papers) and Autophagy in Disease and Therapy (3 papers). Pan Xu collaborates with scholars based in China and United States. Pan Xu's co-authors include Changjun Lv, Xiaodong Song, Jinjin Zhang, Cuiping Mao, Hongbo Li, Meirong Wang, Rongrong Li, Xiaodong Song, Xiangyong Liu and Wen Liu and has published in prestigious journals such as Molecules, Frontiers in Plant Science and Molecular Therapy.

In The Last Decade

Pan Xu

16 papers receiving 486 citations

Peers

Pan Xu
Ramani Soundararajan United States
Yongguang Jiang China
Volha I. Summerhill Russia
Ruan Cox United States
Hshi-chi Koo United States
Yitian Sun China
Zhewei Shi China
Xiaomin Dang China
Ramani Soundararajan United States
Pan Xu
Citations per year, relative to Pan Xu Pan Xu (= 1×) peers Ramani Soundararajan

Countries citing papers authored by Pan Xu

Since Specialization
Citations

This map shows the geographic impact of Pan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan Xu more than expected).

Fields of papers citing papers by Pan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan Xu. The network helps show where Pan Xu may publish in the future.

Co-authorship network of co-authors of Pan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Pan Xu. A scholar is included among the top collaborators of Pan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pan Xu. Pan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yi, Min, Lifei Wu, Chengfu Xu, et al.. (2024). Macrophages and pulmonary fibrosis: a bibliometric and visual analysis of publications from 1990 to 2023. Frontiers in Medicine. 11. 1374177–1374177. 2 indexed citations
2.
Xu, Pan, et al.. (2024). Exploring regulatory network of icariin synthesis in Herba Epimedii through integrated omics analysis. Frontiers in Plant Science. 15. 1409601–1409601. 3 indexed citations
3.
Zhu, Qi, Yunxia Ji, Meirong Wang, et al.. (2023). hucMSCs treatment prevents pulmonary fibrosis by reducing circANKRD42-YAP1-mediated mechanical stiffness. Aging. 15(12). 5514–5534. 9 indexed citations
4.
Xu, Pan, Bo Liu, Rongrong Li, et al.. (2022). MOBT Alleviates Pulmonary Fibrosis through an lncITPF–hnRNP-l-Complex-Mediated Signaling Pathway. Molecules. 27(16). 5336–5336. 2 indexed citations
5.
Xu, Pan, Jinjin Zhang, Meirong Wang, et al.. (2022). hnRNPL-activated circANKRD42 back-splicing and circANKRD42-mediated crosstalk of mechanical stiffness and biochemical signal in lung fibrosis. Molecular Therapy. 30(6). 2370–2387. 33 indexed citations
6.
7.
Zhang, Jinjin, Xiaohong Chen, Hongbin Chen, et al.. (2020). Engeletin ameliorates pulmonary fibrosis through endoplasmic reticulum stress depending on lnc949-mediated TGF-β1-Smad2/3 and JNK signalling pathways. Pharmaceutical Biology. 58(1). 1114–1123. 17 indexed citations
8.
Liu, Jinping, et al.. (2020). Pulmonary metastasis of distal cholangiocarcinoma with multiple cavities in bilateral lungs: A case report. Thoracic Cancer. 11(10). 2998–3000. 1 indexed citations
9.
Chen, Hongbin, Jing Wang, Rongrong Li, et al.. (2020). Astaxanthin attenuates pulmonary fibrosis through lncITPF and mitochondria‐mediated signal pathways. Journal of Cellular and Molecular Medicine. 24(17). 10245–10250. 19 indexed citations
10.
Lu, Guangping, Jinjin Zhang, Xiangyong Liu, et al.. (2019). Regulatory network of two circRNAs and an miRNA with their targeted genes under astilbin treatment in pulmonary fibrosis. Journal of Cellular and Molecular Medicine. 23(10). 6720–6729. 22 indexed citations
11.
Wang, Zhenkai, Jinjin Zhang, Xueying Zhao, et al.. (2019). Crosstalk of mRNA, miRNA, lncRNA, and circRNA and Their Regulatory Pattern in Pulmonary Fibrosis. Molecular Therapy — Nucleic Acids. 18. 204–218. 76 indexed citations
12.
Song, Xiaodong, Pan Xu, Chao Meng, et al.. (2018). lncITPF Promotes Pulmonary Fibrosis by Targeting hnRNP-L Depending on Its Host Gene ITGBL1. Molecular Therapy. 27(2). 380–393. 49 indexed citations
13.
Zhang, Jinjin, Pan Xu, Youlei Wang, et al.. (2015). Astaxanthin prevents pulmonary fibrosis by promoting myofibroblast apoptosis dependent on Drp1‐mediated mitochondrial fission. Journal of Cellular and Molecular Medicine. 19(9). 2215–2231. 58 indexed citations
14.
Song, Xiaodong, Cuiping Mao, Pan Xu, et al.. (2014). Astaxanthin inhibits apoptosis in alveolar epithelial cells type II in vivo and in vitro through the ROS‐dependent mitochondrial signalling pathway. Journal of Cellular and Molecular Medicine. 18(11). 2198–2212. 76 indexed citations
15.
Mao, Cuiping, Jinjin Zhang, Lili Jing, et al.. (2014). MiRNA‐30a inhibits AECs‐II apoptosis by blocking mitochondrial fission dependent on Drp‐1. Journal of Cellular and Molecular Medicine. 18(12). 2404–2416. 41 indexed citations
16.
Li, Hongbo, Jinjin Zhang, Xiaodong Song, et al.. (2014). Alveolar epithelial cells undergo epithelial-mesenchymal transition in acute interstitial pneumonia: a case report. BMC Pulmonary Medicine. 14(1). 67–67. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramani Soundararajan Breakdown of academic impact, for papers by Yongguang Jiang Breakdown of academic impact, for papers by Volha I. Summerhill Breakdown of academic impact, for papers by Ruan Cox Breakdown of academic impact, for papers by Hshi-chi Koo Breakdown of academic impact, for papers by Yitian Sun Breakdown of academic impact, for papers by Zhewei Shi Breakdown of academic impact, for papers by Xiaomin Dang
Rankless by CCL
2026